Jeffrey Jerome Ludwig - Net Worth and Insider Trading
Jeffrey Jerome Ludwig Net Worth
The estimated net worth of Jeffrey Jerome Ludwig is at least $364,635 dollars as of 2024-12-28. Jeffrey Jerome Ludwig is the Chief Commercial Officer of Puma Biotechnology Inc and owns about 118,388 shares of Puma Biotechnology Inc (PBYI) stock worth over $364,635. Details can be seen in Jeffrey Jerome Ludwig's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey Jerome Ludwig has not made any transactions after 2024-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey Jerome Ludwig
Jeffrey Jerome Ludwig Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Jerome Ludwig owns 1 companies in total, including Puma Biotechnology Inc (PBYI) .
Click here to see the complete history of Jeffrey Jerome Ludwig’s form 4 insider trades.
Insider Ownership Summary of Jeffrey Jerome Ludwig
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PBYI | Puma Biotechnology Inc | 2024-07-17 | Chief Commercial Officer |
Jeffrey Jerome Ludwig Latest Holdings Summary
Jeffrey Jerome Ludwig currently owns a total of 1 stock. Jeffrey Jerome Ludwig owns 118,388 shares of Puma Biotechnology Inc (PBYI) as of July 17, 2024, with a value of $364,635.
Latest Holdings of Jeffrey Jerome Ludwig
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PBYI | Puma Biotechnology Inc | 2024-07-17 | 118,388 | 3.08 | 364,635 |
Holding Weightings of Jeffrey Jerome Ludwig
Jeffrey Jerome Ludwig Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey Jerome Ludwig has made a total of 7 transactions in Puma Biotechnology Inc (PBYI) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Puma Biotechnology Inc is the sale of 2,598 shares on July 17, 2024, which brought Jeffrey Jerome Ludwig around $9,613.
Insider Trading History of Jeffrey Jerome Ludwig
- 1
Jeffrey Jerome Ludwig Trading Performance
Jeffrey Jerome Ludwig Ownership Network
Jeffrey Jerome Ludwig Owned Company Details
What does Puma Biotechnology Inc do?
Who are the key executives at Puma Biotechnology Inc?
Jeffrey Jerome Ludwig is the Chief Commercial Officer of Puma Biotechnology Inc. Other key executives at Puma Biotechnology Inc include Chief Financial Officer Maximo F Nougues , See Remarks Douglas M Hunt , and director & 10 percent owner & PRESIDENT & CEO & SECRETARY Alan H Auerbach .
Puma Biotechnology Inc (PBYI) Insider Trades Summary
Over the past 18 months, Jeffrey Jerome Ludwig made 4 insider transaction in Puma Biotechnology Inc (PBYI) with a net sale of 33,708. Other recent insider transactions involving Puma Biotechnology Inc (PBYI) include a net sale of 142,899 shares made by Alan H Auerbach , a net sale of 39,813 shares made by Maximo F Nougues , and a net sale of 24,153 shares made by Douglas M Hunt .
In summary, during the past 3 months, insiders sold 0 shares of Puma Biotechnology Inc (PBYI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 400,782 shares of Puma Biotechnology Inc (PBYI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 400,782 shares.
Puma Biotechnology Inc (PBYI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Puma Biotechnology Inc Insider Transactions
Jeffrey Jerome Ludwig Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey Jerome Ludwig. You might contact Jeffrey Jerome Ludwig via mailing address: C/o Puma Biotechnology, Inc., 10880 Wilshire Boulevard, Suite 2150, Los Angeles Ca 90024.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
